Ignite Creation Date:
2024-05-06 @ 12:17 PM
Last Modification Date:
2024-10-26 @ 12:57 PM
Study NCT ID:
NCT03728816
Status:
UNKNOWN
Last Update Posted:
2018-11-02
First Post:
2018-08-24
Brief Title:
Multicenter Epidemiologic Study of Severe Community Acquired Pneumonia in China
Sponsor:
Ruijin Hospital
Organization:
Ruijin Hospital
Study Overview
Official Title:
Multicenter Epidemiologic Study of Severe Community Acquired Pneumonia in China
Status:
UNKNOWN
Status Verified Date:
2018-11
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is aimed to understand the clinical characteristics etiology and resistance phenotype of major pathogens of SCAP in China through multicenter and prospective investigation Thus to provide epidemiological basis for improving the SCAP diagnosis and treatment protocol suitable for China
Detailed Description:
During the study period all patients who are diagnosed with SCAP and meet the inclusion criteria in the participating unit should be enrolled in the study At the end of the trial each participating unit should complete at least 20 qualified cases and all participating units should have a total of more than 300 qualified cases
1 Learn about the etiology of SCAP in China
2 Grasp the resistance phenotype and molecular epidemiology of major pathogens of SCAP in China
3 Know the important clinical characteristics of SCAP in China including age basic diseases length of hospital stay length of stay in ICU duration of mechanical ventilation clinical manifestations imaging findings complications mortality etc
4 Analyze and clarify the clinical risk factors of affecting SCAP mortality
5 Understand the current situation of antibiotic treatment of SCAP in China
1 Learn about the etiology of SCAP in China
2 Grasp the resistance phenotype and molecular epidemiology of major pathogens of SCAP in China
3 Know the important clinical characteristics of SCAP in China including age basic diseases length of hospital stay length of stay in ICU duration of mechanical ventilation clinical manifestations imaging findings complications mortality etc
4 Analyze and clarify the clinical risk factors of affecting SCAP mortality
5 Understand the current situation of antibiotic treatment of SCAP in China
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None